Registrati | Log in | FAQ      [?] 

Cancer Chemotherapy and Pharmacology

Articles from the last few issues of Cancer Chemotherapy and Pharmacology © Springer
  • Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 745-752.
    by Ijichi, Kei, Adachi, Makoto, Hasegawa, Yasuhisa, Ogawa, Tetsuya, Nakamura, Hideaki, Kudoh, Ayumi, Yasui, Yoshihiro, Murakami, Shingo, Ishizaki, Kanji
  • The role of topoisomerases and RNA transcription in the action of the antitumour benzonaphthyridine derivative SN 28049
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 753-762.
    by Bridewell, David, Porter, Andrew, Finlay, Graeme, Baguley, Bruce
  • A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 763-768.
    by Song, Hong, Do, Young, Chang, Heung, Ryu, Min, Lee, Kyung, Kim, Yeul, Hong, Dae, Cho, Jae, Lee, Kyoung, Kim, Si
  • An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 769-778.
    by Banerji, Udai, Sain, Nivedita, Sharp, Swee, Valenti, Melanie, Asad, Yasmin, Ruddle, Ruth, Raynaud, Florence, Walton, Michael, Eccles, Suzanne, Judson, Ian, Jackman, Ann, Workman, Paul
  • Clinical pharmacokinetics of bevacizumab in patients with solid tumors
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 779-786.
    by Lu, Jian-Feng, Bruno, Rene, Eppler, Steve, Novotny, William, Lum, Bert, Gaudreault, Jacques
  • Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 787-797.
    by Wietrzyk, Joanna, Nevozhay, Dmitry, Milczarek, Magdalena, Filip, Beata, Kutner, Andrzej
  • 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 799-808.
    by Hsu, Tzu-Sheng, Chen, Chinpiao, Lee, Pei-Ting, Chiu, Shu-Jun, Liu, Huei-Fang, Tsai, Chih-Chien, Chao, I Jui-
  • 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 809-809.
    by Hsu, Tzu-Sheng, Chen, Chinpiao, Lee, Pei-Ting, Chiu, Shu-Jun, Liu, Huei-Fang, Tsai, Chih-Chien, Chao, I Jui-
  • Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 811-819.
    by Heer, Pieter, Sandel, Maro, Guertens, Gunther, Boeck, Gert, Koudijs, Margaretha, Nagelkerke, , Junggeburt, Jan, Bruijn, Ernst, Velde, Cornelis, Kuppen, Peter
  • Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 821-830.
    by Munkelt, Doreen, Koehl, Ulrike, Kloess, Stephan, Zimmermann, Stefanie-Yvonne, Kalaaoui, Rabia, Wehner, Sibylle, Schwabe, Dirk, Lehrnbecher, Thomas, Schubert, Ralf, Kreuter, Joerg, Klingebiel, Thomas, Esser, Ruth
  • 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 831-840.
    by Kar, Siddhartha, Wang, Meifang, Carr, Brian
  • Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 841-847.
    by Heijns, Joan, Burg, Maria, Gelder, Teun, Fieren, Marien, Bruijn, Peter, Gaast, Ate, Loos, Walter
  • S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 849-855.
    by Furuse, Junji, Okusaka, Takuji, Boku, Narikazu, Ohkawa, Shinichi, Sawaki, Akira, Masumoto, Toshikazu, Funakoshi, Akihiro
  • Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 857-865.
    by Ji, Chao, Cao, Cong, Lu, Shan, Kivlin, Rebecca, Amaral, Ashley, Kouttab, Nicola, Yang, Hui, Chu, Wenming, Bi, Zhigang, Di, Wen, Wan, Yinsheng
  • Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 867-873.
    by Nabekura, Tomohiro, Yamaki, Takeshi, Ueno, Kazuyuki, Kitagawa, Shuji
  • Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 875-880.
    by Ku, Geoffrey, Ilson, David, Schwartz, Lawrence, Capanu, Marinela, Oreilly, Eileen, Shah, Manish, Kelsen, David, Schwartz, Gary
  • In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 881-891.
    by Rassnick, Kenneth, Muindi, Josephia, Johnson, Candace, Balkman, Cheryl, Ramnath, Nithya, Yu, Wei-Dong, Engler, Kristie, Page, Rodney, Trump, Donald
  • 2-Methoxyestradiol reverses doxorubicin resistance in human breast tumor xenograft
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 893-902.
    by Azab, Samar, Salama, Salama, Hassan, Memy, Khalifa, Amani, El-Demerdash, Ebtehal, Fouad, Hala, Al-Hendy, Ayman, Abdel-Naim, Ashraf
  • Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 903-910.
    by Bartsch, Rupert, Wenzel, Catharina, Gampenrieder, Simon, Pluschnig, Ursula, Altorjai, Gabriela, Rudas, Margaretha, Mader, Robert, Dubsky, Peter, Rottenfusser, Andrea, Gnant, Michael, Zielinski, Christoph, Steger, Guenther
  • Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 911-919.
    by Rodon, Jordi, Garrison, Mitchell, Hammond, Lisa, Bono, Johann, Smith, Lon, Forero, Leonardo, Hao, Desiree, Takimoto, Chris, Lambert, John, Pandite, Lini, Howard, Maria, Xie, Hongsheng, Tolcher, Anthony
  • Androgen receptor expression in prostate cancer stem cells: is there a conundrum?
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 921-923.
    by Sharifi, Nima, Hurt, Elaine, Farrar, William
  • Oxaliplatin-induced immune mediated thrombocytopenia
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 925-927.
    by Beg, Muhammad, Komrokji, Rami, Ahmed, Kashif, Safa, Malek
  • Successful treatment of non-islet cell tumor hypoglycemia in hepatocellular carcinoma with doxorubicin
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5. (October 2008), pp. 929-930.
    by Kampitak, Thatchai
  • Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 559-568.
    by Ma, Rundi, Song, Gang, You, Wenbing, Yu, Lijian, Su, Weiming, Liao, Mingneng, Zhang, Yongping, Huang, Laizhen, Zhang, Xiaoyu, Yu, Tingxi
  • c-Jun-NH2-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 569-576.
    by Takada, Eiko, Hata, Kikumi, Mizuguchi, Junichiro
  • Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 577-584.
    by Kitada, Noriaki, Takara, Kohji, Minegaki, Tetsuya, Itoh, Chihiro, Tsujimoto, Masayuki, Sakaeda, Toshiyuki, Yokoyama, Teruyoshi
  • Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 585-594.
    by Anuchapreeda, Songyot, Tima, Singkome, Duangrat, Chadarat, Limtrakul, Pornngarm
  • Biological properties of 4-methyl-2,7-diamino-5,10-diphenyl-4,9-diazapyrenium hydrogensulfate (ADAP)
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 595-604.
    by Marczi, Saska, Glavas-Obrovac, Ljubica, Belovari, Tatjana, Stojkovic, Ranko, Ivankovic, Sinisa, Seric, Vatroslav, Piantanida, Ivo, Zinic, Mladen
  • Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 605-620.
    by Zerbe, Laura, Dwyer-Nield, Lori, Fritz, Jason, Redente, Elizabeth, Shroyer, Robert, Conklin, Elizabeth, Kane, Shawn, Tucker, Chris, Eckhardt, , Gustafson, Daniel, Iwata, Kenneth, Malkinson, Alvin
  • Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 621-629.
    by Bigioni, , Benzo, , Irrissuto, , Lopez, , Curatella, , Maggi, , Manzini, , Crea, , Caroli, , Cubadda, , Binaschi,
  • A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 631-646.
    by Chow, Laura, Eckhardt, , Obryant, Cindy, Schultz, Mary, Morrow, Mark, Grolnic, Stacy, Basche, Michele, Gore, Lia
  • Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 647-653.
    by Gamblin, , Egorin, Merrill, Zuhowski, Eleanor, Lagattuta, Theodore, Herscher, Laurie, Russo, Angelo, Libutti, Steven, Alexander, , Dedrick, Robert, Bartlett, David
  • Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 655-665.
    by Formelli, Franca, Cavadini, Elena, Luksch, Roberto, Garaventa, Alberto, Villani, Maria, Appierto, Valentina, Persiani, Stefano
  • Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 667-672.
    by Torrisi, Rosalba, Balduzzi, Alessandra, Ghisini, Raffaella, Rocca, Andrea, Bottiglieri, Luca, Giovanardi, Filippo, Veronesi, Paolo, Luini, Alberto, Orlando, Laura, Viale, Giuseppe, Goldhirsch, Aron, Colleoni, Marco
  • A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 673-678.
    by Reni, , Berardi, , Mambrini, , Pasetto, , Cereda, , Ferrari, , Cascinu, , Cantore, , Mazza, , Grisanti,
  • Pharmacokinetics of heated intraperitoneal oxaliplatin
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 679-683.
    by Ferron, , Dattez, , Gladieff, , Delord, -P, Pierre, , Lafont, , Lochon, , Chatelut,
  • Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 685-688.
    by Atzpodien, Jens, Terfloth, Kerstin, Fluck, Michael, Reitz, Martina
  • BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 689-697.
    by Kang, Hyo, Kim, Hee, Kwon, Sang, Kang, Brian, Eling, Thomas, Lee, Sang, Bae, Insoo
  • Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 699-706.
    by Rogers, Danny, Nylander, Karen, Mi, Zhiping, Hu, Tong, Schor, Nina
  • Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 707-716.
    by Zhang, -Y, King, , Pelletier, , Wong,
  • Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 717-725.
    by Fabi, Alessandra, Metro, Giulio, Papaldo, Paola, Mottolese, Marcella, Melucci, Elisa, Carlini, Paolo, Sperduti, Isabella, Russillo, Michelangelo, Gelibter, Alain, Ferretti, Gianluigi, Tomao, Silverio, Milella, Michele, Cognetti, Francesco
  • A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 727-733.
    by Schelman, William, Morgan-Meadows, Sherry, Bailey, Howard, Holen, Kyle, Thomas, James, Eickhoff, Jens, Brandon, Heidi, Oliver, Kate, Alberti, Dona, Wilding, George
  • Imatinib inhibition of fludarabine uptake in T-lymphocytes
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 735-739.
    by Woodahl, Erica, Wang, Joanne, Heimfeld, Shelly, Ren, Aaron, Mccune, Jeannine
  • Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 4. (September 2008), pp. 741-743.
    by Gentile, Massimo, Lucia, Eugenio, Iorio, Caterina, Vigna, Ernesto, Mazzone, Carla, Morelli, Rosellina, Bisconte, Maria, Gentile, Carlo, Morabito, Fortunato
  • A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 1. (June 2008), pp. 1-9.
    by Park, Se, Nam, Eunmi, Bang, Soo-Mee, Cho, Eun, Shin, Dong, Lee, Jae
  • Sequential vinorelbinecapecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 1. (June 2008), pp. 11-18.
    by Ghosn, Marwan, Kattan, Joseph, Farhat, Fadi, Younes, Fariha, Nasr, Fadi, Moukadem, Walid, Gasmi, Jamal, Chahine, Georges
  • Preclinical studies of treosulfan demonstrate potent activity in Ewings sarcoma
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 1. (June 2008), pp. 19-31.
    by Werner, Sebastian, Mendoza, Arnulfo, Hilger, Ralf, Erlacher, Miriam, Reichardt, Wilfried, Lissat, Andrej, Konanz, Claudia, Uhl, Marcus, Niemeyer, Charlotte, Khanna, Chand, Kontny, Udo
  • Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 1. (June 2008), pp. 33-41.
    by Logan, Richard, Gibson, Rachel, Bowen, Joanne, Stringer, Andrea, Sonis, Stephen, Keefe, Dorothy
  • Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 1. (June 2008), pp. 43-49.
    by Tomonaga, Nanae, Nakamura, Yoichi, Soda, Hiroshi, Nagashima, Seiji, Nakano, Hirofumi, Kinoshita, Akitoshi, Fukuda, Masaaki, Fukuda, Minoru, Takatani, Hiroshi, Soejima, Yoshifumi, Oka, Mikio, Kohno, Shigeru
  • In vitro evaluation of the effects of gefitinib on the modulation of cytotoxic activity of selected anticancer agents in a panel of human ovarian cancer cell lines
    Cancer Chemotherapy and Pharmacology, Vol. 62, No. 1. (June 2008), pp. 51-58.
    by Smith, Judith, Gaikwad, Anjali, Yu, Jiang, Wolf, Judith, Brown, Jubilee, Ramondetta, Lois, Stewart, Clinton
    • Puoi citare questa pagina come: http://www.citeulike.org/journal/klu-280

    Result page: 1 2 3 4 5 6 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.